REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioCryst Pharmaceuticals, Inc. (NQ: BCRX)
1.660 USD  -0.020 (-1.19%)
Official Closing Price  /  Updated: 4:00 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about BioCryst Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Traders Get Bullish on Shares of BioCryst Pharmaceuticals, Shares Up 7.2% (BCRX)
June 22, 2012
from Comtex SmarTrend® News Briefs
Biotech Industry Showing Impressive Gains for Investors in 2012
June 08, 2012
The Paragon Report Provides Stock Research on BioCryst and Threshold Read More
from Marketwired News Releases
BioCryst Pharmaceuticals Up 16.5%, Shares Break Through Resistance (BCRX)
June 06, 2012
from Comtex SmarTrend® News Briefs
Morning Movers 06/06: (LEE) (BCRX) (INVN) Higher; (TPX) (MFRM) (SCSS) (FCEL) Lower
June 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7498460 for the full story. Read More
from StreetInsider.com News Articles
BioCryst (Nasdaq: BCRX) Trading +12% on Gout Program Results
June 06, 2012
Northern, WI 6/6/12 ( StreetBeat ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq:BCRX ) today announced that additional safety and efficacy results from its BCX4208 gout program will be presented at the... Read More
from Street Beat: Articles
BioCryst (Nasdaq: BCRX) Trading +12% on Gout Program Results
June 06, 2012
Northern, WI 6/6/12 ( StreetBeat ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq:BCRX ) today announced that additional safety and efficacy results from its BCX4208 gout program will be presented at the... Read More
from Street Beat: Articles
BioCryst (Nasdaq: BCRX) Trading +12% on Gout Program Results
June 06, 2012
Northern, WI 6/6/12 ( StreetBeat ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq:BCRX ) today announced that additional safety and efficacy results from its BCX4208 gout program will be presented at the... Read More
from Street Beat: Articles
BioCryst (Nasdaq: BCRX) Trading +12% on Gout Program Results
June 06, 2012
Northern, WI 6/6/12 ( StreetBeat ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq:BCRX ) today announced that additional safety and efficacy results from its BCX4208 gout program will be presented at the... Read More
from Street Beat: Articles
BioCryst Pharmaceuticals (BCRX) Director Buys 20,000 Shares
June 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7497205 for the full story. Read More
from StreetInsider.com News Articles
BioCryst Pharmaceuticals (BCRX) to Present Three Posters on BCX4208 as Gout Treatment
June 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7497123 for the full story. Read More
from StreetInsider.com News Articles
BioCryst Presents Results from Its BCX4208 Gout Program at the Annual European Congress of Rheumatology
June 06, 2012
from Business Wire News Releases
BioCryst to Present at Two Upcoming Investor Conferences
May 22, 2012
from Business Wire News Releases
Stock to Watch: BioCryst Pharmaceuticals Up 5.9% (BCRX)
May 07, 2012
from Comtex SmarTrend® News Briefs
Savient (SVNT) Shares Hit as BioCryst (BCRX) Gets FDA Guidance for Gout Treatment Approval
May 07, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7408887 for the full story. Read More
from StreetInsider.com News Articles
BioCryst (Nasdaq: BCRX) Provides Corporate Update and Reports Q1 2012 Financial Results
May 07, 2012
Atlanta, GA 5/7/12 ( StreetBeat ) -- -BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) today announced financial results for the first quarter ended March 31, 2012. “We just completed our end of Phase 2... Read More
from Street Beat: Articles
BioCryst (Nasdaq: BCRX) Provides Corporate Update and Reports Q1 2012 Financial Results
May 07, 2012
Atlanta, GA 5/7/12 ( StreetBeat ) -- -BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) today announced financial results for the first quarter ended March 31, 2012. “We just completed our end of Phase 2... Read More
from Street Beat: Articles
BioCryst (Nasdaq: BCRX) Provides Corporate Update and Reports Q1 2012 Financial Results
May 07, 2012
Atlanta, GA 5/7/12 ( StreetBeat ) -- -BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) today announced financial results for the first quarter ended March 31, 2012. “We just completed our end of Phase 2... Read More
from Street Beat: Articles
BioCryst (Nasdaq: BCRX) Provides Corporate Update and Reports Q1 2012 Financial Results
May 07, 2012
Atlanta, GA 5/7/12 ( StreetBeat ) -- -BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) today announced financial results for the first quarter ended March 31, 2012. “We just completed our end of Phase 2... Read More
from Street Beat: Articles
BioCryst Pharma (BCRX) Posts Narrower than Expected Q1 Loss of 13c/Share; Reaffirms
May 07, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7406936 for the full story. Read More
from StreetInsider.com News Articles
BioCryst Provides Corporate Update and Reports First Quarter 2012 Financial Results
May 07, 2012
from Business Wire News Releases
BioCryst to Present at Two Upcoming Investor Conferences
May 01, 2012
from Business Wire News Releases
BioCryst to Report First Quarter 2012 Financial Results on May 7, 2012
April 25, 2012
from Business Wire News Releases
BioCryst Pharmaceuticals Shares Up 71.1% Since SmarTrend's Buy Recommendation (BCRX)
March 28, 2012
from Comtex SmarTrend® News Briefs
Find A Biotech Stock That's On A Winning Streak (AVII, BCRX, INFI)
March 22, 2012
Investors follow momentum trends because positive sentiment on a company can cause the momentum to persist. Read More
from Investopedia Advisor Commentary
Morning Movers 03/13: (BBX) (MDS) (WOLF) (CKEC) Higher; (CCIX) (COOL) (BCRX) Lower
March 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7264326 for the full story. Read More
from StreetInsider.com News Articles
Pre-Open Movers 3/13 (MDS) (CKEC) (WOLF) Higher; (SB) (COOL) (XPO) Lower (more...)
March 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7264031 for the full story. Read More
from StreetInsider.com News Articles
BioCryst (BCRX) Seeks to Correct Erroneous Patent on HCV Inhibitor
March 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7263176 for the full story. Read More
from StreetInsider.com News Articles
Countdown Has Begun for 7 Rising Biotechs
March 12, 2012
If you're looking for cutting-edge companies that have a chance to triple or quadruple in the coming months and years, don't look any further than today's best small biotechs, writes Mike Murphy of New... Read More
from MoneyShow.com
Stocks To Watch On Wednesday, March 07
March 06, 2012
( click to enlarge ) I’m looking at a possible double bottom reversal on Rubicon Technology, Inc. (NASDAQ:RBCN) stock chart. I know that it’s too early to say for certain but looking at the technical... Read More
category MSI , RBCN , PEIX , and 5 more.
from DailyMarkets.com
Stocks to Watch on Wednesday, March 07
March 06, 2012
category MSI , RBCN , BCRX , and 2 more.
from AC Investor Blog
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here